These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22290095)

  • 41. Current axial-flow devices--the HeartMate II and Jarvik 2000 left ventricular assist devices.
    John R
    Semin Thorac Cardiovasc Surg; 2008; 20(3):264-72. PubMed ID: 19038737
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beating heart implantation of a wearable NOVACOR left-ventricular assist device.
    Scheld HH; Hammel D; Schmid C; Weyand M; Deng M; Möllhoff T; Kerber S
    Thorac Cardiovasc Surg; 1996 Apr; 44(2):62-6. PubMed ID: 8782329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low molecular weight heparin as an alternative to unfractionated heparin in the immediate postoperative period after left ventricular assist device implantation.
    Sandner SE; Zimpfer D; Zrunek P; Steinlechner B; Rajek A; Schima H; Wolner E; Wieselthaler GM
    Artif Organs; 2008 Oct; 32(10):819-22. PubMed ID: 18959671
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subcutaneous low molecular weight heparin for management of anticoagulation in infants on excor ventricular assist device.
    Ghez O; Liesner R; Karimova A; Ng C; Goldman A; van Doorn C
    ASAIO J; 2006; 52(6):705-7. PubMed ID: 17117062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of Antiplatelet Agents and Anticoagulants in Patients with Gastrointestinal Bleeding.
    Abraham NS
    Gastrointest Endosc Clin N Am; 2015 Jul; 25(3):449-62. PubMed ID: 26142031
    [TBL] [Abstract][Full Text] [Related]  

  • 47. First clinical experience with the Incor left ventricular assist device.
    Schmid C; Tjan TD; Etz C; Schmidt C; Wenzelburger F; Wilhelm M; Rothenburger M; Drees G; Scheld HH
    J Heart Lung Transplant; 2005 Sep; 24(9):1188-94. PubMed ID: 16143232
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review.
    Carrel TP; Klingenmann W; Mohacsi PJ; Berdat P; Althaus U
    J Heart Valve Dis; 1999 Jul; 8(4):392-8. PubMed ID: 10461238
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of platelet function during left ventricular support with the Incor and Excor system.
    Etz C; Welp H; Rothenburger M; Tjan TD; Wenzelburger F; Schmidt C; Scheld HH; Schmid C
    Heart Surg Forum; 2004; 7(5):E423-7. PubMed ID: 15799917
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Continuous-flow left ventricular assist device and the right ventricle.
    Puhlman M
    AACN Adv Crit Care; 2012; 23(1):86-90. PubMed ID: 22290094
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute gastrointestinal bleeding after percutaneous coronary intervention.
    Wallace MC; Rankin J; Forbes GM
    Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):211-21. PubMed ID: 22375526
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acquired coagulopathy in patients with left ventricular assist devices.
    Muslem R; Caliskan K; Leebeek FWG
    J Thromb Haemost; 2018 Mar; 16(3):429-440. PubMed ID: 29274191
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical outcomes are similar in pulsatile and nonpulsatile left ventricular assist device recipients.
    Feller ED; Sorensen EN; Haddad M; Pierson RN; Johnson FL; Brown JM; Griffith BP
    Ann Thorac Surg; 2007 Mar; 83(3):1082-8. PubMed ID: 17307463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety and effectiveness of low dosing of double antiplatelet therapy during long-term left ventricular support with the INCOR system.
    Attisani M; Centofanti P; La Torre M; Campanella A; Sansone F; Rinaldi M
    J Artif Organs; 2010 Dec; 13(4):202-6. PubMed ID: 21127929
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.
    Pagani FD; Miller LW; Russell SD; Aaronson KD; John R; Boyle AJ; Conte JV; Bogaev RC; MacGillivray TE; Naka Y; Mancini D; Massey HT; Chen L; Klodell CT; Aranda JM; Moazami N; Ewald GA; Farrar DJ; Frazier OH;
    J Am Coll Cardiol; 2009 Jul; 54(4):312-21. PubMed ID: 19608028
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gastrointestinal bleeding with continuous-flow left ventricular assist devices.
    Amer S; Shah P; Hassan S
    Clin J Gastroenterol; 2015 Apr; 8(2):63-7. PubMed ID: 25614135
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Can the occurrence of gastrointestinal bleeding in nonpulsatile left ventricular assist device patients provide clues for the reversal of arteriosclerosis?
    Stein LH; Elefteriades JA
    Cardiol Clin; 2011 Nov; 29(4):641-5. PubMed ID: 22062216
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extracorporeal membrane oxygenation as perioperative right ventricular support in patients with biventricular failure undergoing left ventricular assist device implantation.
    Scherer M; Sirat AS; Moritz A; Martens S
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):939-44; discussion 944. PubMed ID: 21071240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.
    Uriel N; Pak SW; Jorde UP; Jude B; Susen S; Vincentelli A; Ennezat PV; Cappleman S; Naka Y; Mancini D
    J Am Coll Cardiol; 2010 Oct; 56(15):1207-13. PubMed ID: 20598466
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.